FDA grants Mednition’s KATE AI Breakthrough Device Designation for early sepsis detection
Mednition, a leader in clinical artificial intelligence (AI) healthcare solutions, has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its KATE Sepsis, recognizing the AI-powered solution as a significant advancement in the early detection of sepsis.